Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

An overview of new biomolecular pathways in pathogen-related cancers.

Tornesello ML, Buonaguro L, Buonaguro FM.

Future Oncol. 2015;11(11):1625-39. doi: 10.2217/fon.15.87.

PMID:
26043216
2.

Cellular prognostic markers in hepatocellular carcinoma.

Buonaguro L, Tagliamonte M, Petrizzo A, Damiano E, Tornesello ML, Buonaguro FM.

Future Oncol. 2015;11(11):1591-8. doi: 10.2217/fon.15.39.

PMID:
26043213
3.

Foreword. Cancer biomarkers.

Buonaguro FM, Tornesello ML, Buonaguro L.

Future Oncol. 2015;11(11):1585-6. doi: 10.2217/fon.15.74. No abstract available.

4.

Correction: Genetic Diversity of the KIR/HLA System and Susceptibility to Hepatitis C Virus-Related Diseases.

De Re V, Caggiari L, De Zorzi M, Repetto O, Zignego AL, Izzo F, Tornesello ML, Buonaguro FM, Mangia A, Sansonno D, Racanelli V, De Vita S, Pioltelli P, Vaccher E, Beretta M, Mazzaro C, Libra M, Gini A, Zucchetto A, Cannizzaro R, De Paoli P.

PLoS One. 2015 May 15;10(5):e0128849. doi: 10.1371/journal.pone.0128849. eCollection 2015. No abstract available.

5.

Update on Head and Neck Cancer: Current Knowledge on Epidemiology, Risk Factors, Molecular Features and Novel Therapies.

Pezzuto F, Buonaguro L, Caponigro F, Ionna F, Starita N, Annunziata C, Buonaguro FM, Tornesello ML.

Oncology. 2015;89(3):125-36. doi: 10.1159/000381717. Epub 2015 May 8.

PMID:
25967534
6.

Novel metronomic chemotherapy and cancer vaccine combinatorial strategy for hepatocellular carcinoma in a mouse model.

Tagliamonte M, Petrizzo A, Napolitano M, Luciano A, Arra C, Maiolino P, Izzo F, Tornesello ML, Aurisicchio L, Ciliberto G, Buonaguro FM, Buonaguro L.

Cancer Immunol Immunother. 2015 May 6. [Epub ahead of print]

PMID:
25944003
7.

Tobacco smoke activates human papillomavirus 16 p97 promoter and cooperates with high-risk E6/E7 for oxidative DNA damage in lung cells.

Peña N, Carrillo D, Muñoz JP, Chnaiderman J, Urzúa U, León O, Tornesello ML, Corvalán AH, Soto-Rifo R, Aguayo F.

PLoS One. 2015 Apr 1;10(4):e0123029. doi: 10.1371/journal.pone.0123029. eCollection 2015.

8.

Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseases.

De Re V, Caggiari L, De Zorzi M, Repetto O, Zignego AL, Izzo F, Tornesello ML, Buonaguro FM, Mangia A, Sansonno D, Racanelli V, De Vita S, Pioltelli P, Vaccher E, Beretta M, Mazzaro C, Libra M, Gini A, Zucchetto A, Cannizzaro R, De Paoli P.

PLoS One. 2015 Feb 20;10(2):e0117420. doi: 10.1371/journal.pone.0117420. eCollection 2015.

9.

The XIX century smallpox prevention in Naples and the risk of transmission of human blood-related pathogens.

Buonaguro FM, Tornesello ML, Buonaguro L.

J Transl Med. 2015 Jan 27;13:33. doi: 10.1186/s12967-015-0400-9.

10.

Antigen-specific vaccines for cancer treatment.

Tagliamonte M, Petrizzo A, Tornesello ML, Buonaguro FM, Buonaguro L.

Hum Vaccin Immunother. 2014;10(11):3332-46. doi: 10.4161/21645515.2014.973317.

PMID:
25483639
11.

TP53 and PIK3CA gene mutations in adenocarcinoma, squamous cell carcinoma and high-grade intraepithelial neoplasia of the cervix.

Tornesello ML, Annunziata C, Buonaguro L, Losito S, Greggi S, Buonaguro FM.

J Transl Med. 2014 Sep 16;12:255. doi: 10.1186/s12967-014-0255-5.

12.

HPV-related oropharyngeal cancers: from pathogenesis to new therapeutic approaches.

Tornesello ML, Perri F, Buonaguro L, Ionna F, Buonaguro FM, Caponigro F.

Cancer Lett. 2014 Sep 1;351(2):198-205. doi: 10.1016/j.canlet.2014.06.003. Epub 2014 Jun 24. Review.

PMID:
24971935
13.

Cancer diagnostic and predictive biomarkers.

Buonaguro FM, Pauza D, Tornesello ML, Hainaut P, Franco R, Marincola FM.

Biomed Res Int. 2014;2014:980163. doi: 10.1155/2014/980163. Epub 2014 Apr 3. No abstract available.

14.

Formation of self-assembled triple-layered rotavirus-like particles (tlRLPs) by constitutive co-expression of VP2, VP6, and VP7 in stably transfected high-five insect cell lines.

Shoja Z, Tagliamonte M, Jalilvand S, Mollaei-Kandelous Y, De Stradis A, Tornesello ML, Buonaguro FM, Buonaguro L.

J Med Virol. 2015 Jan;87(1):102-11. doi: 10.1002/jmv.23973. Epub 2014 May 5.

PMID:
24797918
15.

Human Papillomavirus Infection and Cervical Neoplasia among Migrant Women Living in Italy.

Tornesello ML, Giorgi Rossi P, Buonaguro L, Buonaguro FM; HPV Prevalence Italian Working Group.

Front Oncol. 2014 Feb 20;4:31. doi: 10.3389/fonc.2014.00031. eCollection 2014.

16.

Prediction of individual immune responsiveness to a candidate vaccine by a systems vaccinology approach.

Petrizzo A, Tagliamonte M, Tornesello ML, Buonaguro FM, Buonaguro L.

J Transl Med. 2014 Jan 15;12:11. doi: 10.1186/1479-5876-12-11.

17.

Viral and cellular biomarkers in the diagnosis of cervical intraepithelial neoplasia and cancer.

Tornesello ML, Buonaguro L, Giorgi-Rossi P, Buonaguro FM.

Biomed Res Int. 2013;2013:519619. doi: 10.1155/2013/519619. Epub 2013 Dec 9. Review.

18.

Oncolytic virus therapies.

Buonaguro FM, Tornesello ML, Izzo F, Buonaguro L.

Pharm Pat Anal. 2012 Nov;1(5):621-7. doi: 10.4155/ppa.12.65. Review.

PMID:
24236929
19.

VLPs and particle strategies for cancer vaccines.

Ungaro F, Conte C, Quaglia F, Tornesello ML, Buonaguro FM, Buonaguro L.

Expert Rev Vaccines. 2013 Oct;12(10):1173-93. doi: 10.1586/14760584.2013.836909. Review.

PMID:
24124878
20.

Electrochemotherapy as "new standard of care" treatment for cutaneous Kaposi's sarcoma.

Di Monta G, Caracò C, Benedetto L, La Padula S, Marone U, Tornesello ML, Buonaguro FM, Simeone E, Ascierto PA, Mozzillo N.

Eur J Surg Oncol. 2014 Jan;40(1):61-6. doi: 10.1016/j.ejso.2013.09.002. Epub 2013 Sep 12.

PMID:
24075826
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk